Renaissance Technologies’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.99M | Buy |
1,751,200
+167,075
| +11% | +$381K | 0.01% | 1661 |
|
|
2025
Q1 | $2.46M | Buy |
1,584,125
+965,183
| +156% | +$1.5M | ﹤0.01% | 1876 |
|
|
2024
Q4 | $1.45M | Buy |
618,942
+368,071
| +147% | +$865K | ﹤0.01% | 2264 |
|
|
2024
Q3 | $911K | Sell |
250,871
-894,185
| -78% | -$3.25M | ﹤0.01% | 2496 |
|
|
2024
Q2 | $3.98M | Buy |
1,145,056
+821,156
| +254% | +$2.86M | 0.01% | 1455 |
|
|
2024
Q1 | $2.07M | Buy |
323,900
+164,300
| +103% | +$1.05M | ﹤0.01% | 2012 |
|
|
2023
Q4 | $1.03M | Sell |
159,600
-114,079
| -42% | -$735K | ﹤0.01% | 2389 |
|
|
2023
Q3 | $638K | Buy |
273,679
+122,479
| +81% | +$286K | ﹤0.01% | 2601 |
|
|
2023
Q2 | $360K | Buy |
151,200
+42,800
| +39% | +$102K | ﹤0.01% | 3044 |
|
|
2023
Q1 | $199K | Buy |
108,400
+62,100
| +134% | +$114K | ﹤0.01% | 3284 |
|
|
2022
Q4 | $88K | Buy |
46,300
+21,100
| +84% | +$40.1K | ﹤0.01% | 3656 |
|
|
2022
Q3 | $54K | Buy |
25,200
+12,400
| +97% | +$26.6K | ﹤0.01% | 3738 |
|
|
2022
Q2 | $36K | Buy |
+12,800
| New | +$36K | ﹤0.01% | 4049 |
|
|
2021
Q2 | – | Sell |
-81,588
| Closed | -$467K | – | 3442 |
|
|
2021
Q1 | $467K | Buy |
81,588
+632
| +0.8% | +$3.62K | ﹤0.01% | 2931 |
|
|
2020
Q4 | $724K | Buy |
80,956
+27,300
| +51% | +$244K | ﹤0.01% | 2660 |
|
|
2020
Q3 | $625K | Sell |
53,656
-18,744
| -26% | -$218K | ﹤0.01% | 2742 |
|
|
2020
Q2 | $1.16M | Sell |
72,400
-88,096
| -55% | -$1.41M | ﹤0.01% | 2470 |
|
|
2020
Q1 | $961K | Buy |
160,496
+119,796
| +294% | +$717K | ﹤0.01% | 2445 |
|
|
2019
Q4 | $537K | Sell |
40,700
-8,300
| -17% | -$110K | ﹤0.01% | 2880 |
|
|
2019
Q3 | $609K | Sell |
49,000
-41,096
| -46% | -$511K | ﹤0.01% | 2797 |
|
|
2019
Q2 | $1.45M | Buy |
+90,096
| New | +$1.45M | ﹤0.01% | 2513 |
|